Literature DB >> 20200940

Dramatic increase in cortical thickness induced by femoral marrow ablation followed by a 3-month treatment with PTH in rats.

Qing Zhang1, Jodi Carlson, Hua Zhu Ke, Jiliang Li, Michael Kim, Kieran Murphy, Nozer Mehta, James Gilligan, Agnès Vignery.   

Abstract

We previously reported that following mechanical ablation of the marrow from the midshaft of rat femurs, there is a rapid and abundant but transient growth of bone, and this growth is enhanced and maintained over a 3-week period by the bone anabolic hormone parathyroid hormone (PTH). Here, we asked whether further treatment with PTH or bisphosphonates can extend the half-life of the new bone formed in lieu of marrow. We subjected the left femur of rats to mechanical marrow ablation and treated the animals 5 days a week with PTH for 3 weeks (or with vehicle as a control) to replace the marrow by bone. Some rats were euthanized and used as positive controls or treated with vehicle, PTH, or the bisphosphonate alendronate for a further 9 weeks. We subjected both femurs from each rat to soft X-ray, peripheral quantitative computed tomography (pQCT), micro-computed tomography (microCT), dynamic histomorphometry analysis, and biomechanical testing. We also determined the concentrations of serum osteocalcin to confirm the efficacy of PTH. Treatment with PTH for 3 months dramatically enhanced endosteal and periosteal bone formation, leading to a 30% increase in cortical thickness. In contrast, alendronate protected the bone that had formed in the femoral marrow cavity after marrow ablation and 3 weeks of treatment with PTH but failed to promote endosteal bone growth or to improve the biomechanical properties of ablated femurs. We further asked whether calcium-phosphate cements could potentiate the formation of bone after marrow ablation. Marrow cavities from ablated femurs were filled with one of two calcium-phosphate cements, and rats were treated with PTH or PBS for 84 days. Both cements helped to protect the new bone formed after ablation. To some extent, they promoted the formation of bone after ablation, even in the absence of any anabolic hormone. Our data therefore expand the role of PTH in bone engineering and open new avenues of investigation to the field of regenerative medicine and tissue engineering. Local bone marrow aspiration in conjunction with an anabolic agent, a bisphosphonate, or a calcium-phosphate cement might provide a new platform for rapid preferential site-directed bone growth in areas of high bone loss. (c) 2010 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200940     DOI: 10.1002/jbmr.25

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  3 in total

1.  Cutting edge: Parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2.

Authors:  Laurie K McCauley; Jesmond Dalli; Amy J Koh; Nan Chiang; Charles N Serhan
Journal:  J Immunol       Date:  2014-06-02       Impact factor: 5.422

2.  Additive Effects of Mechanical Marrow Ablation and PTH Treatment on de Novo Bone Formation in Mature Adult Rats.

Authors:  Qing Zhang; Christopher Miller; Jesse Bible; Jiliang Li; Xiaoqing Xu; Nozer Mehta; James Gilligan; Agnès Vignery; Jodi A Carlson Scholz
Journal:  Cells       Date:  2012-12-05       Impact factor: 6.600

3.  Effects of magnetic resonance-guided high-intensity focused ultrasound ablation on bone mechanical properties and modeling.

Authors:  Sin Yuin Yeo; Andrés J Arias Moreno; Bert van Rietbergen; Natalie D Ter Hoeve; Paul J van Diest; Holger Grüll
Journal:  J Ther Ultrasound       Date:  2015-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.